https://orcid.org/0000-0001-9296-6344
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
- Cancer Statistics Review. 1975–2013 – Previous version - SEER Cancer Statistics Review. SEER. Available from: https://seer.cancer.gov/archive/csr/1975_2013/index.html
- Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111:1827–1833.
- Shahrabi S, Behzad MM, Jaseb K, et al. Thrombocytopenia in leukemia: pathogenesis and prognosis. Histol Histopathol. 2018;33:895–908.
- Sirop SJ, Al-Kali A, Begna K, et al. Lack of prognostic significance of monosomal karyotype and absolute lymphocyte count at diagnosis in philadelphia chromosome negative acute lymphoblastic leukemia. Blood. 2012;120:1476–1476.
- Jain N, Roberts KG, Jabbour E, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129:572–581.
- Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013;368:1771–1780.
- Tantiworawit A, Rattanathammethee T, Chai-Adisaksopha C, et al. Outcomes of adult acute lymphoblastic leukemia in the era of pediatric-inspired regimens: a single-center experience. Int J Hematol 2019;110:295–305.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
- Common Terminology Criteria for Adverse Events (CTCAE). Protocol development. CTEP; Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
- Therneau T. A package for survival analysis in R_. R package version 3.1–11.
- RStudio Team. RStudio: integrated development for R. Boston (MA): RStudio, Inc.; 2019.
- Amin HM, Yang Y, Shen Y, et al. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. Leukemia. 2005;19:1567–1572.
- Ai L, Mu S, Hu Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis. Cancer Cell Int. 2018;18:61.
- Rafsanjani KA, Falahati V, Kiumarsi A, et al. The association between red cell distribution width and mortality in pediatric acute lymphoblastic leukemia. J Neoplasm. 2017;2:1–3.